A novel poloxamers/hyaluronic acid in situ forming hydrogel for drug delivery: rheological, mucoadhesive and in vitro release properties.
The influence of hyaluronic acid (HA) on the gelation properties of poloxamers blends has been studied with the aim of engineering thermosensitive and mucoadhesive polymeric platforms for drug delivery. The gelation temperature (T(gel)), viscoelastic properties and mucoadhesive force of the systems were investigated and optimised by means of rheological analyses. Poloxamers micellar diameter was evaluated by photon correlation spectroscopy (PCS). Moreover in order to explore the feasibility of these platforms for drug delivery, the optimised systems were loaded with acyclovir and its release properties studied in vitro. By formulating poloxamers/HA platforms, at specific concentrations, it was possible to obtain a thermoreversible gel with a T(gel) close to body temperature. The addition of HA did not hamper the self assembling process of poloxamers just delaying the gelation temperature of few Celsius degrees. Furthermore, HA presence led to a strong increase of the poloxamer rheological properties thus indicating possible HA interactions with micelles through secondary bonds, such as hydrogen ones, which reinforce the gel structure. These interactions could also explain PCS results which show, in systems containing HA, aggregates with hydrodynamic diameters much higher than those of poloxamer micelles. Mucoadhesion experiments showed a rheological synergism between poloxamers/HA gels and mucin dispersion which led to a change of the flow behaviour from a quite Newtonian one of the separate solutions to a pseudoplastic one of their mixture. In vitro release experiments indicated that the optimised platform was able to prolong and control acyclovir release for more than 6h.
Mayol
Laura
L
Department of Pharmaceutical and Toxicological Chemistry, University of Naples Federico II, Via D. Montesano 49, Naples, Italy.
Quaglia
Fabiana
F
Borzacchiello
Assunta
A
Ambrosio
Luigi
L
La Rotonda
Maria I
MI
D000212:Acyclovir / Q000737:chemistry; D000268:Adhesiveness; D000818:Animals; D000998:Antiviral Agents / Q000737:chemistry; D002626:Chemistry, Pharmaceutical; D004337:Drug Carriers; D004548:Elasticity; D005240:Feasibility Studies; D005752:Gastric Mucins / Q000737:chemistry* / Q000378:metabolism; D006820:Hyaluronic Acid / Q000737:chemistry* / Q000378:metabolism; D020100:Hydrogels; D007700:Kinetics; D008823:Micelles; D009883:Ophthalmic Solutions / Q000737:chemistry; D017785:Photons; D020442:Poloxamer / Q000737:chemistry* / Q000378:metabolism; D012212:Rheology; D012995:Solubility; D013050:Spectrometry, Fluorescence; D013552:Swine; D013678:Technology, Pharmaceutical / Q000379:methods*; D013696:Temperature; D014783:Viscosity
D000998:Antiviral Agents; D004337:Drug Carriers; D005752:Gastric Mucins; D020100:Hydrogels; D008823:Micelles; D009883:Ophthalmic Solutions; D020442:Poloxamer; D006820:Hyaluronic Acid; D000212:Acyclovir